A plasmid digene construction designed before [Tchuraev, R.N. (1982) J. Gen. Biol. 43, 79-87] has been realised, including feedback by repressing proteins with given trigger regime of gene functioning. Experimental tests of the expected epigene properties of the obtained pECPI recombinant plasmid involving lacI and cI(857) regulatory genes have shown a phenomenon of steady inheritance of two alternative epigenotypes lacI(1)cI(0) and lacI(0)cI(1), as well as an external toggle switch through metabolitic and temperature signals from one inherited functional state of the cyclic digene system into another. Thus, we have constructed a hereditary unit of a specific kind, namely, a two-component stationary epigene with preset properties.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0014-5793(00)02300-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Autophagy, a relevant process for metabolic health and type-2 diabetes.
Nutr Hosp
April 2023
Departamento de Nutrición y Ciencias de los Alimentos. Facultad de Farmacia. Universidad Complutense de Madrid.
Autophagy is a very active process that plays an important role in cell and organ differentiation and remodelling, being a crucial system to guarantee health. This physiological process is activated in starvation and inhibited in the presence of nutrients. This short review comments on the three types of autophagy: macroautophagy, microautophagy, and chaperone-mediated autophagy, as well as different aspects that control autophagy and its relationship with health and degenerative diseases.
View Article and Find Full Text PDFThe EPIGENE network: A French initiative to harmonize and improve the nationwide diagnosis of monogenic epilepsies.
Eur J Med Genet
March 2022
Department of Medical Genetics, Member of ERN-EpiCARE, HFME, University Hospitals of Lyon (HCL), Claude Bernard Lyon1 University, Lyon, France. Electronic address:
Article Synopsis
- The EPIGENE network, formed in 2014 by a group of specialists in genetics and neurology, aims to enhance the diagnosis of Mendelian epileptic disorders in France through advanced sequencing techniques.
- Since its creation, the network has expanded to include more centers, resulting in the development of a multigene panel that has grown from 68 to 144 genes, with a significant diagnostic success rate of 31% from over 4,000 analyzed cases.
- Looking ahead, the network plans to offer whole-genome sequencing for young patients with severe epilepsy as part of the upcoming 2025 French Genomic Medicine Plan, fostering collaborations with the rare epilepsies reference center.
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.
Clin Cancer Res
February 2021
Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
Purpose: At diagnosis, colorectal cancer presents with synchronous peritoneal metastasis in up to 10% of patients. The peritoneum is poorly characterized with respect to its superspecialized microenvironment. Our aim was to describe the differences between peritoneal metastases and their matched primary tumors excised simultaneously at the time of surgery.
View Article and Find Full Text PDFSafety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors.
J Immunother Cancer
October 2020
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Background: MEDI9197 is an intratumorally administered toll-like receptor 7 and 8 agonist. In mice, MEDI9197 modulated antitumor immune responses, inhibited tumor growth and increased survival. This first-time-in-human, phase 1 study evaluated MEDI9197 with or without the programmed cell death ligand-1 (PD-L1) inhibitor durvalumab and/or palliative radiation therapy (RT) for advanced solid tumors.
View Article and Find Full Text PDFDevelopment and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors.
JAMA Dermatol
August 2016
Sydney School of Public Health, University of Sydney, Sydney, Australia.
Importance: Identifying individuals at high risk of melanoma can optimize primary and secondary prevention strategies.
Objective: To develop and externally validate a risk prediction model for incident first-primary cutaneous melanoma using self-assessed risk factors.
Design, Setting, And Participants: We used unconditional logistic regression to develop a multivariable risk prediction model.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!